Details for Patent: 10,077,271
Which drugs does patent 10,077,271 protect, and when does it expire?
Patent 10,077,271 protects KOMZIFTI and is included in one NDA.
This patent has thirty-one patent family members in twenty-three countries.
Summary for Patent: 10,077,271
| Title: | Methods and compositions for inhibiting the interaction of menin with MLL proteins |
| Abstract: | The present disclosure provides compositions and methods of use to inhibit the interaction of menin with MLL1, MLL2 and MLL-fusion oncoproteins. The compositions and methods of use are useful for the treatment of leukemia, solid cancers, diabetes and other diseases dependent on activity of MLL1, MLL2, MLL fusion proteins, and/or menin. |
| Inventor(s): | Jolanta Grembecka, Tomasz Cierpicki, Dmitry Borkin, Jonathan Pollock, Liansheng Li, Tao Wu, Jun Feng, Pingda Ren, Yi Liu, Szymon Klossowski |
| Assignee: | Wellspring Biosciences LLC , University of Michigan System , Kura Oncology Inc |
| Application Number: | US15/829,604 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 10,077,271
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kura | KOMZIFTI | ziftomenib | CAPSULE;ORAL | 220305-001 | Nov 13, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,077,271
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 104020 | ⤷ Start Trial | |||
| Australia | 2016270002 | ⤷ Start Trial | |||
| Brazil | 112017026085 | ⤷ Start Trial | |||
| Canada | 2985053 | ⤷ Start Trial | |||
| China | 107922378 | ⤷ Start Trial | |||
| China | 116217581 | ⤷ Start Trial | |||
| China | 121800804 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
